Sanofi Comprehensive Income 2012-2026 | SNY

Sanofi comprehensive income for the quarter ending March 31, 2026 was $0M, a 0% increase year-over-year.

  • Sanofi comprehensive income for 2024 was $2.571B, a 3931.53% decline from 2023.
  • Sanofi comprehensive income for 2023 was $-0.067B, a 104.39% decline from 2022.
  • Sanofi comprehensive income for 2022 was $1.529B, a 250.78% decline from 2021.

Sanofi Comprehensive Income 2012-2026 | SNY

  • Sanofi comprehensive income for 2024 was $2.571B, a 3931.53% decline from 2023.
  • Sanofi comprehensive income for 2023 was $-0.067B, a 104.39% decline from 2022.
  • Sanofi comprehensive income for 2022 was $1.529B, a 250.78% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B